Trends in the treatment of type 1 diabetes with CSII vs MDI: a Canadian retrospective observational study

被引：0
|
作者：
Terres, J. Alfonso Ross [1 ]
Jabbour, A. D. [1 ]
Freeman, M. A. [1 ]
机构：
[1] GSK, Mississauga, ON, Canada
来源：
DIABETOLOGIA | 2012年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1028
引用
收藏
页码：S422 / S422
页数：1
相关论文
共 50 条
  • [1] MDI VS CSII IN PREGNANCY WITH TYPE1 DIABETES
    Torlone, E.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A12 - A13
  • [2] Vascular Health in Type 1 Diabetes: CSII vs. MDI
    Januszewski, Andrzej S.
    Karschimkus, Connie
    Mcauley, Sybil
    O'Neal, David N.
    Jenkins, Alicia J.
    [J]. DIABETES, 2012, 61 : A228 - A228
  • [3] DIETARY HABITS IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES USING CSII VS. MDI: A DESCRIPTIVE TRANSVERSAL OBSERVATIONAL STUDY
    Scaramuzza, A.
    Bosetti, A.
    Ferrari, M.
    Redaelli, F.
    De Angelis, L.
    Giani, E.
    Macedoni, M.
    Comaschi, V.
    Ungheri, S.
    Platerote, F.
    Zuccotti, G. V.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 : A51 - A51
  • [4] SHORT TERM GLYCAEMIC VARIABILITY IN CSII VS MDI IN ADULTS WITH TYPE 1 DIABETES
    Scott, E. S.
    McGrath, R. T.
    Januszewski, A. S.
    Fulcher, G. R.
    Jenkins, A. J.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A129 - A130
  • [5] EVALUATION OF TREATMENT SATISFACTION IN PATIENTS WITH TYPE 1 DIABETES USING CSII AND MDI
    Cander, S.
    Gul, O. Oz
    Deligonul, A.
    Ersoy, C.
    Erturk, E.
    Tuncel, E.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 : A35 - A36
  • [6] Pregnancy outcome and glycemic control in women with type 1 diabetes: A retrospective comparison between CSII and MDI treatment
    Talaviya, Praful A.
    Saboo, Banshi D.
    Joshi, Shashank R.
    Padhiyar, Jayendra N.
    Chandarana, Hardik K.
    Shah, Smita J.
    Vyas, Chintal K.
    Shah, Asha N.
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2013, 7 (02) : 68 - 71
  • [7] CSII VS MDI IN CHILDREN WITH TYPE 1 DIABETES DURING AN AEROBIC/ANAEROBIC EXERCISE: AN IN-FIELD STUDY
    Rabbone, I.
    Scaramuzza, A. E.
    Tinti, D.
    Massarini, M.
    Schiaffini, R.
    Fintini, D.
    Giani, E.
    Di Gianni, V. R.
    Gazzarri, A.
    Macedoni, M.
    Cappa, M.
    Cerutti, F.
    Zuccotti, G. V.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 : A18 - A19
  • [8] CGM combined with either MDI or CSII is superior to standalone MDI or CSII in type 1 diabetes: 2 years of follow-up in the COMISAIR study
    Soupal, J.
    Petruzelkova, L.
    Flekac, M.
    Dankova, M.
    Haskova, A.
    Matoulek, M.
    Mikes, O.
    Pelcl, T.
    Skrha, J.
    Svacina, S.
    Prazny, M.
    [J]. DIABETOLOGIA, 2017, 60 : S328 - S329
  • [9] THE PUMP TREATMENT (CSII) IN TYPE 2 DIABETES COMPARED TO INTENSIFIED INSULIN ANALOG (MDI) TREATMENT
    Gruberova, J.
    Jankovec, Z.
    Lacigova, S.
    Tomesova, J.
    Rusavy, Z.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 : A40 - A41
  • [10] COST-CONSEQUENCE ANALYSIS OF CSII VS. MDI: A CANADIAN PERSPECTIVE
    Sadri, H.
    Bereza, B. G.
    Longo, C. J.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A290 - A290
12345